VOR.NASDAQVor Biopharma INC

SCHEDULE: FMR LLC Discloses 1.7% Stake in VOR Biopharma

Sentiment:

Beneficial Ownership Amendment

📋All filings for Vor Biopharma INC
🔒Login to Follow

FMR LLC and Abigail P. Johnson report a 1.7% passive beneficial ownership in VOR Biopharma Inc. common stock as of June 30, 2025.

Summary

  • FMR LLC and Abigail P. Johnson collectively beneficially own 2,092,686 shares of VOR Biopharma Inc. common stock.
  • This ownership represents 1.7% of the total outstanding common stock.
  • The shares are held in the ordinary course of business and not for the purpose of changing or influencing control of VOR Biopharma Inc.
  • FMR LLC holds sole voting power over 2,086,202 shares and sole dispositive power over 2,092,686 shares.
  • Abigail P. Johnson holds sole dispositive power over 2,092,686 shares.

Sentiment

Score: 5

Explanation: The filing is a neutral, factual disclosure of a passive ownership stake. It does not contain positive or negative financial or operational news about the issuer.

Positives

  • The investment by FMR LLC, a prominent financial institution, indicates continued passive interest in VOR Biopharma Inc.
  • The filing explicitly states the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer, suggesting a stable, non-activist investment.

Negatives

  • The filing does not present any explicit negative financial or operational information about VOR Biopharma Inc.
  • The 1.7% stake represents a relatively small, passive position, which typically does not signal significant strategic shifts or strong conviction.

Risks

  • No specific risks related to VOR Biopharma Inc.'s operations or financial health are disclosed in this ownership filing.
  • The filing confirms the investment is not for control, mitigating risks associated with activist investor intentions.

Future Outlook

Not applicable, as this filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance from the issuer.

Industry Context

This Schedule 13G filing is a routine disclosure of institutional ownership and does not provide specific industry context or competitive analysis for VOR Biopharma Inc. or the broader biopharma sector.

Key Dates

DateDescription
2023-05-23Effective date of Power of Attorney for Richard Bourgelas, authorizing him to sign on behalf of FMR LLC and Abigail P. Johnson.
2023-08-08Date of previous Schedule 13G filing by FMR LLC (accession number -23-002397) where the Power of Attorney was incorporated by reference.
2025-06-30Date of event which requires filing of this statement, representing the reporting period end for the beneficial ownership.
2025-08-05Filing date of this Schedule 13G Amendment No. 6.

Keywords

VOR Biopharma, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investment, Biopharma

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.